Your World, Fully Explored.
Published loading...Updated

PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene - Pacific Biosciences (NASDAQ:PACB)

Summary by Benzinga
MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally recognized leader in blood typing genomics, as an official distributor in China. The distribution arrangement is designed to expand access to PacBio's HiFi long-read sequencing technology in clinical and research settings, with a focus on tr…

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Thursday, May 22, 2025.
Sources are mostly out of (0)